SGIOF - Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript
2025-07-29 08:35:31 ET
Shionogi & Co., Ltd. (SGIOY)
Q1 2025 Earnings Conference Call
July 28, 2025 03:30 AM ET
Company Participants
John A. Keller - Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director
Masako Kudou - Corporate Officer & SVP of Corporate Strategy Division
Takeki Uehara - Corporate Officer and SVP of Drug Development & Regulatory
Takuji Fujiwara - VP, Finance & Accounting Department
Toshinobu Iwasaki - Senior Executive Officer & SVP of
Healthcare Business Supervisory Unit - Corporate Participant
Yoshimasa Kyokawa - Vice President of Corporate Communications & Secretary Office
Conference Call Participants
Akinori Ueda - Goldman Sachs Group, Inc., Research Division
Fumiyoshi Sakai - UBS Securities., Research Division
Hidemaru Yamaguchi - Citigroup Inc., Research Division
Miki Sogi - Bernstein, Research Division
Seiji Wakao - JPMorgan Chase & Co, Research Division
Shinichiro Muraoka - Morgan Stanley, Research Division
Presentation
Yoshimasa Kyokawa
Thank you all very much for joining us today despite your busy schedules. My name is Kyokawa, Vice of President of Corporate Communications Department of SHIONOGI. We are starting SHIONOGI & Co., Ltd.’s financial results briefing for the first quarter of fiscal 2025.
First of all, I would like to introduce today's speakers. John Keller, Director of the Board, Senior Vice President, R&D Supervisory Unit....
Shionogi & Co., Ltd. (SGIOY) Q1 2025 Earnings Call Transcript